Companies / Pear Therapeutics, Inc.
Pear Therapeutics, Inc.
PEARTHMAUCIK 1835567
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 3, 2021 | Schwab Andrew J. Director | Grant Grant or award | Class A Common Stock | $2.00M | +200K +6.30% | 3,372,769 | low |
| Apr 10, 2023 | 5AM Partners IV, LLC 10% owner | Sell Open-market sale | Class A Common Stock | $1.54M | -12.8M -100.00% | 0 | medium |
| Sep 6, 2022 | 5AM Partners IV, LLC 10% owner | Sell Open-market sale | Class A Common Stock | $705.0K | -299K -2.09% | 13,965,926 | medium |
| Sep 14, 2022 | 5AM Partners IV, LLC 10% owner | Sell Open-market sale | Class A Common Stock | $530.9K | -274K -2.02% | 13,251,776 | medium |
| Sep 8, 2022 | 5AM Partners IV, LLC 10% owner | Sell Open-market sale | Class A Common Stock | $528.8K | -292K -2.11% | 13,525,440 | medium |
| Sep 15, 2022 | 5AM Partners IV, LLC 10% owner | Sell Open-market sale | Class A Common Stock | $473.9K | -262K -1.98% | 12,989,936 | medium |
| Apr 10, 2023 | 5AM Partners IV, LLC 10% owner | Sell Open-market sale | Class A Common Stock | $380.7K | -3.2M -94.07% | 200,000 | medium |
| Aug 18, 2022 | 5AM Partners IV, LLC 10% owner | Sell Open-market sale | Class A Common Stock | $331.5K | -214K -1.48% | 14,264,640 | medium |